Burns and Scalds
Conditions
Keywords
aromatherapy, burns, child, infant
Brief summary
The goal of this trial is to see if aromatherapy in addition to pain medication, will help manage pain in pediatric burn patients during their first burn dressing change. Participants aged 2 months to 7 years old will be randomly assigned to usual care (pain medication only) or to receive aromatherapy in addition to pain medication prior to their first burn dressing change. The main question it aims to answer is: -Does aromatherapy plus pain medication decrease pain more than pain medication alone for young children receiving their first burn dressing change? All participants will receive the standard pain medications and have their pain assessed on medication administration (prior to aromatherapy for the intervention group), prior to dressing change (after aromatherapy for the intervention group), and 15 minutes after the dressing change is complete. Once the final pain assessment is complete, there is no more information needed from participants for the purposes of the study. All participants will continue to follow up in the clinic for the remaining dressing changes as needed.
Interventions
OTHERAromatherapy
Aromatherapy diffusion is a blend of three essential oils, bergamot mint, patchouli, and sweet orange.
Sponsors
KK Women's and Children's Hospital
National Cancer Centre, Singapore
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Intervention model description
Randomized control trial comparing aromatherapy with usual care
Eligibility
Sex/Gender
ALL
Age
2 Months to 7 Years
Healthy volunteers
No
Inclusion criteria
* Seen in outpatient burn center * Burns not covering more than 7.5% of body surface area * First burn dressing change * Second degree burns * Scalding, flame, or contact burns
Exclusion criteria
* Allergy/hypersensitivity to essential oils, or any components of the aromatherapy formula * Airway/hypersensitivity to fragrances, paint fumes, or turpentine * Respiratory conditions (e.g. asthma, reactive airway disease, recent wheezing) * Inhalation injury 1. Thermal injury: Caused by direct thermal damage which affects upper airways resulting in edema, stridor and upper airway obstruction 2. Chemical injury to airways and lung parenchyma from products of combustion 3. Systemic poisoning from carbon monoxide and/or cyanide * Surgery for burn * Infection of burn * Burns of the face * Burns requiring Acticoat dressing * Delayed burns (those that have been previously treated outside of the hospital, but have not healed and require further treatment)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain score as measured by Face, Legs, Activity, Cry, and Consolability (FLACC) scale with first burn dressing change | FLACC to be completed upon arrival in burn center (baseline), immediately prior to burn dressing change (preprocedural), and 15 minutes after burn dressing change is complete (postprocedural). | Zero is equivalent to no pain and 10 indicates severe pain |
Countries
Singapore
Contacts
CONTACTEugenie Spiguel, PhD
CONTACTJoanne Cheng, DNP
PRINCIPAL_INVESTIGATOREugenie Spiguel, PhD
KK Women and Children's Hospital
Outcome results
None listed